Methods of expanding human embryonic stem cells
First Claim
1. A method of expanding hES cells free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor, and conditioned media, comprising:
- (a) introducing hES cells in a cell culture medium consisting of minimal essential medium, a progestin, and a β
-human chorionic gonadotropin (β
hCG) agonist; and
(b) incubating the cells at a temperature of about 34°
C. to about 38°
C. in an environment of about 3.5% to about 6% carbon dioxide for about 12 hours to about 48 hours.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a pharmaceutical composition comprising of preparations of human embryonic stem (hES) cells and their derivatives and methods for their transplantation into the human body, wherein transplantation results in the clinical reversal of symptoms, cure, stabilization or arrest of degeneration of a wide variety of presently incurable and terminal medical conditions, diseases and disorders. The invention further relates to novel processes of preparing novel stem cell lines which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media. This invention further relates to the isolation, culture, maintenance, expansion, differentiation, storage, and preservation of such stem cells.
-
Citations
11 Claims
-
1. A method of expanding hES cells free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor, and conditioned media, comprising:
-
(a) introducing hES cells in a cell culture medium consisting of minimal essential medium, a progestin, and a β
-human chorionic gonadotropin (β
hCG) agonist; and(b) incubating the cells at a temperature of about 34°
C. to about 38°
C. in an environment of about 3.5% to about 6% carbon dioxide for about 12 hours to about 48 hours. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
Specification